Neoadjuvant gefitinib therapy: a potential standard therapy for non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Nishida T 

PROVIDER: S-EPMC9096278 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature